All financial services providers are in the business of buying, selling, slicing, and repackaging risk—by financial means. So ...

Recent periods of financial stress and the proliferation of risks across the financial system are fueling the development of ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

The financials sector faces multiple challenges in 2025, including recession risks, rate cut uncertainty, high valuations, ...

H.B. Fuller Company (NYSE: FUL) today reported financial results for its first quarter that ended March 1, 2025.

Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, is announcing its financial results for the three and twelve months ended ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

“Our 2025 EPS growth estimate of up 16 per cent (from up 17 per cent; consensus up 15 per cent) aligns with guidance for EPS ...

More hikes in raw material prices and freight costs would pressure Supor’s earnings, as they typically account for the bulk of the cost of sales. Supor has a healthy balance sheet with minimal net ...

We recently compiled a list of the 11 Best Fundamentally Strong Penny Stocks to Buy Now. In this article, we are going to ...

Also seeing opportunities to grow its store network in Australia, Mr. Shreedhar moved Dollarama to an “outperform” rating ...